Rezolute RZLT
NASDAQ RZLT
$4.57 +0.03 (+0.77%)
As of: Sep 4, 2026 · 1:40 PM EDT

Rezolute (RZLT) Interest & Investment Income (2012 - 2026)

Rezolute (RZLT) posted Interest & Investment Income of -$162000.0 for Q1 2026, down 111.2% sequentially from $1.4 million in Q4 2025, and down 671.43% YoY from $28350.0 in Q1 2025.

Analysis

Rezolute (RZLT) Interest & Investment Income (2012 - 2026) Analysis & Trends

Rezolute has reported Interest & Investment Income for 15 years, with the latest figure at -$162000.0 in Q1 2026.

  • Quarterly Interest & Investment Income fell 671.43% year-over-year to -$162000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 55.69% YoY) and the FY2025 annual result came in at $5.5 million, up 12.57% from the prior year.
  • Interest & Investment Income retreated to -$162000.0 in Q1 2026 per RZLT's latest filing, from $1.4 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $4.6 million in Q2 2024 and troughed at -$162000.0 in Q1 2026.
  • A 5-year average of $1.1 million and a median of $624500.0 in 2022 frame the typical range for Interest & Investment Income.
  • The sharpest annual moves came in 2022 and 2026: Interest & Investment Income soared 6600.0% in 2022, then plunged 671.43% in 2026.
  • Over 5 years, Interest & Investment Income stood at $849000.0 in 2022, then soared by 53.47% to $1.3 million in 2023, then increased by 3.15% to $1.3 million in 2024, then grew by 7.66% to $1.4 million in 2025, then plunged by 111.2% to -$162000.0 in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered -$162000.0, $1.4 million, and $56000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.26 Bn 131.41 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.64 Bn 77.64 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 48.00 Mn
4 Moderna 57.83 Bn 52.69 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 35.58 Mn
6 BeOne Medicines 39.94 Bn 34.84 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.19 Bn 31.88 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 5.13 Mn
9 Insmed 27.35 Bn 26.19 Bn 358.27 Mn 10.98 Mn
10 Rezolute 475.98 Mn 475.98 Mn - 1.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.20 Mn
Dec 31, 2025 1.45 Mn
Sep 30, 2025 1.68 Mn
Jun 30, 2025 1.45 Mn
Mar 31, 2025 1.12 Mn
Dec 31, 2024 1.34 Mn
Sep 30, 2024 1.58 Mn
Jun 30, 2024 1.04 Mn
Mar 31, 2024 1.12 Mn
Dec 31, 2023 1.30 Mn
Sep 30, 2023 1.40 Mn
Jun 30, 2023 1.48 Mn
Mar 31, 2023 1.48 Mn
Dec 31, 2022 849,000.00
Sep 30, 2022 400,000.00
Jun 30, 2022 -478,000.00
Mar 31, 2022 -442,000.00
Dec 31, 2021 -445,000.00
Sep 30, 2021 -443,000.00
Jun 30, 2021 -437,000.00